3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
11
Neoplasms
5
Parasomnias
4
Depression
3
Weight Loss
2
Tuberous Sclerosis
2
Smith-Magenis Syndrome
2
Sleep Wake Disorders
2
Polycystic Ovary Syndrome
2
Pain
2
Lung Neoplasms
2
Fatigue
2
Cachexia
2
Autism Spectrum Disorder
2
Anxiety Disorders
2
Angelman Syndrome
2
Uveal Melanoma
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Disorders, Circadian Rhythm
1
Relapsed Malignant Solid Tumor
1
Radiodermatitis
1
Radiation Injuries
1
Quality of Life
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm Metastasis
1
Melanoma
1
Leukoplakia, Oral
1
Keratosis, Actinic
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Low-Level Light Therapy
6
Standard of Care
5
Petrolatum
3
Norepinephrine
3
triethanolamine
2
sapropterin
2
Sodium Chloride
2
Radiotherapy
2
Curcumin
2
Biafine
2
eucerin
1
epigallocatechin gallate
1
dimethicone
1
cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion
1
calcipotriene
1
Zinc Oxide
1
Triamcinolone Acetonide
1
Thioctic Acid
1
Sodium Hypochlorite
1
Silver Sulfadiazine
1
Radiotherapy, Conformal
1
Practice Guidelines as Topic
1
Melatonin
1
Laser Therapy
1
Hydrogel, Polyethylene Glycol Dimethacrylate
1
Hydrocortisone
1
Gels
1
Dimethyl Sulfoxide
1
Centella asiatica extract
1
Catechin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Radiodermatitis
×
Melatonin
×
Clear all
NCT03716583
2021-09-10
MELADERM
Herlev Hospital
Phase 2
Completed
48 enrolled